暗网禁地

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2019 $ 26,461,428 $ 18,666 $ 68,562,727 $ (70,000) $ (42,049,965)
Beginning balance (in shares) at Apr. 30, 2019 18,665,551
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 889,484 889,484
Common stock issued for stock options exercised for cash 237,713 $ 113 237,600
Common stock issued for stock options exercised for cash (in shares) 112,826
Common stock issued for cashless stock options exercised 0 $ 182 (182)
Common stock issued for cashless stock options exercised (in shares) 182,207
Common stock issued for cashless warrant exercise 0 $ 77 (77)
Common stock issued for cashless warrant exercise (in shares) 76,929
Amortization of warrant based cost 18,565 18,565
Amortization of restricted stock issued for services 73,350 73,350
Restricted Stock Issued for Services, subject to vesting 0 $ 104 (104)
Restricted Stock Issued for Services, subject to vesting (in shares) 104,803
Net loss (2,713,450) (2,713,450)
Ending balance at Oct. 31, 2019 24,967,090 $ 19,142 69,781,363 (70,000) (44,763,415)
Ending balance (in shares) at Oct. 31, 2019 19,142,316
Beginning balance at Jul. 31, 2019 24,969,790 $ 18,914 69,146,123 (70,000) (44,125,247)
Beginning balance (in shares) at Jul. 31, 2019 18,913,527
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 391,067 391,067
Common stock issued for stock options exercised for cash 192,522 $ 90 192,432
Common stock issued for stock options exercised for cash (in shares) 90,950
Common stock issued for cashless stock options exercised 0 $ 80 (80)
Common stock issued for cashless stock options exercised (in shares) 80,313
Common stock issued for cashless warrant exercise 0 $ 58 (58)
Common stock issued for cashless warrant exercise (in shares) 57,526
Amortization of warrant based cost 9,125 9,125
Amortization of restricted stock issued for services 42,754 42,754
Net loss (638,168) (638,168)
Ending balance at Oct. 31, 2019 24,967,090 $ 19,142 69,781,363 (70,000) (44,763,415)
Ending balance (in shares) at Oct. 31, 2019 19,142,316
Beginning balance at Apr. 30, 2020 41,747,957 $ 21,771 89,505,216 (70,000) (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020 21,770,520
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for stock options exercised for cash 1,269,982
Common stock issued for stock options exercised for cash (in shares) 415,175
Common stock issued for warrants exercised for cash $ 1,081,792
Common stock issued for warrants exercised for cash (in shares) 192,049
Ending balance at Jul. 31, 2020 $ 43,678,736 $ 22,378 92,378,584 (70,000) (48,652,226)
Ending balance (in shares) at Jul. 31, 2020 22,377,744
Beginning balance at Apr. 30, 2020 41,747,957 $ 21,771 89,505,216 (70,000) (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020 21,770,520
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 2,318,658 2,318,658
Common stock issued for stock options exercised for cash 2,215,315 $ 918 2,214,397
Common stock issued for stock options exercised for cash (in shares) 917,587
Common stock issued for cashless stock options exercised 0 $ 22 (22)
Common stock issued for cashless stock options exercised (in shares) 22,339
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601
Common stock issued for conversion of Convertible Notes (in shares) 1,398,602
Common stock issued for vested restricted stock units 0 $ 132 (132)
Common stock issued for vested restricted stock units (in shares) 132,109
Common stock issued for warrants exercised for cash 1,081,792 $ 192 1,081,600
Common stock issued for warrants exercised for cash (in shares) 192,049
Modification charge for warrants exercised 25,966 25,966
Amortization of warrant based cost 18,250 18,250
Cancellation of Treasury Stock 0 $ (17) (69,983) 70,000
Cancellation of Treasury Stock (in shares) (16,667)
Net loss (5,313,721) (5,313,721)
Ending balance at Oct. 31, 2020 52,094,217 $ 24,417 105,092,551 0 (53,022,751)
Ending balance (in shares) at Oct. 31, 2020 24,416,539
Beginning balance at Jul. 31, 2020 43,678,736 $ 22,378 92,378,584 (70,000) (48,652,226)
Beginning balance (in shares) at Jul. 31, 2020 22,377,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 1,831,548 1,831,548
Common stock issued for stock options exercised for cash 945,332 $ 502 944,830
Common stock issued for stock options exercised for cash (in shares) 502,412
Common stock issued for cashless stock options exercised 0 $ 22 (22)
Common stock issued for cashless stock options exercised (in shares) 22,339
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601
Common stock issued for conversion of Convertible Notes (in shares) 1,398,602
Common stock issued for vested restricted stock units 0 $ 132 (132)
Common stock issued for vested restricted stock units (in shares) 132,109
Amortization of warrant based cost 9,125 9,125
Cancellation of Treasury Stock 0 $ (17) (69,983) 70,000
Cancellation of Treasury Stock (in shares) (16,667)
Net loss (4,370,525) (4,370,525)
Ending balance at Oct. 31, 2020 $ 52,094,217 $ 24,417 $ 105,092,551 $ 0 $ (53,022,751)
Ending balance (in shares) at Oct. 31, 2020 24,416,539